These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 29738538

  • 1. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
    Landau D, London L, Bandach I, Segev Y.
    PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
    [Abstract] [Full Text] [Related]

  • 2. Down-Regulation of Cardiac Erythropoietin Receptor and its Downstream Activated Signal Transducer Phospho-STAT-5 in a Rat Model of Chronic Kidney Disease.
    Hertzberg-Bigelman E, Barashi R, Levy R, Cohen L, Ben-Shoshan J, Keren G, Entin-Meer M.
    Isr Med Assoc J; 2016 Jun; 18(6):326-30. PubMed ID: 27468524
    [Abstract] [Full Text] [Related]

  • 3. Iron-hepcidin dysmetabolism, anemia and renal hypoxia, inflammation and fibrosis in the remnant kidney rat model.
    Garrido P, Ribeiro S, Fernandes J, Vala H, Bronze-da-Rocha E, Rocha-Pereira P, Belo L, Costa E, Santos-Silva A, Reis F.
    PLoS One; 2015 Jun; 10(4):e0124048. PubMed ID: 25867633
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease.
    Del Balzo U, Signore PE, Walkinshaw G, Seeley TW, Brenner MC, Wang Q, Guo G, Arend MP, Flippin LA, Chow FA, Gervasi DC, Kjaergaard CH, Langsetmo I, Guenzler V, Liu DY, Klaus SJ, Lin A, Neff TB.
    J Pharmacol Exp Ther; 2020 Aug; 374(2):342-353. PubMed ID: 32487538
    [Abstract] [Full Text] [Related]

  • 6. Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD).
    Noonan ML, Clinkenbeard EL, Ni P, Swallow EA, Tippen SP, Agoro R, Allen MR, White KE.
    Physiol Rep; 2020 Jun; 8(11):e14434. PubMed ID: 32476270
    [Abstract] [Full Text] [Related]

  • 7. The Hepcidin-Anemia Axis: Pathogenesis of Anemia in Chronic Kidney Disease.
    Nakanishi T, Kimura T, Kuragano T.
    Contrib Nephrol; 2019 Jun; 198():124-134. PubMed ID: 30991414
    [Abstract] [Full Text] [Related]

  • 8. A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial.
    Brigandi RA, Johnson B, Oei C, Westerman M, Olbina G, de Zoysa J, Roger SD, Sahay M, Cross N, McMahon L, Guptha V, Smolyarchuk EA, Singh N, Russ SF, Kumar S, PHI112844 Investigators.
    Am J Kidney Dis; 2016 Jun; 67(6):861-71. PubMed ID: 26827289
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85-3934 (Molidustat) stimulates erythropoietin production without hypertensive effects.
    Flamme I, Oehme F, Ellinghaus P, Jeske M, Keldenich J, Thuss U.
    PLoS One; 2014 Jun; 9(11):e111838. PubMed ID: 25392999
    [Abstract] [Full Text] [Related]

  • 11. Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents.
    Tanaka T, Nangaku M.
    Exp Cell Res; 2012 May 15; 318(9):1068-73. PubMed ID: 22414872
    [Abstract] [Full Text] [Related]

  • 12. Cerebral adaptations to chronic anemia in a model of erythropoietin-deficient mice exposed to hypoxia.
    El Hasnaoui-Saadani R, Pichon A, Marchant D, Olivier P, Launay T, Quidu P, Beaudry M, Duvallet A, Richalet JP, Favret F.
    Am J Physiol Regul Integr Comp Physiol; 2009 Mar 15; 296(3):R801-11. PubMed ID: 19109375
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Palmitate deranges erythropoietin production via transcription factor ATF4 activation of unfolded protein response.
    Anusornvongchai T, Nangaku M, Jao TM, Wu CH, Ishimoto Y, Maekawa H, Tanaka T, Shimizu A, Yamamoto M, Suzuki N, Sassa R, Inagi R.
    Kidney Int; 2018 Sep 15; 94(3):536-550. PubMed ID: 29887316
    [Abstract] [Full Text] [Related]

  • 15. The volatile anesthetic isoflurane differentially suppresses the induction of erythropoietin synthesis elicited by acute anemia and systemic hypoxemia in mice in an hypoxia-inducible factor-2-dependent manner.
    Kai S, Tanaka T, Matsuyama T, Suzuki K, Hirota K.
    Eur J Pharmacol; 2014 Jun 05; 732():43-9. PubMed ID: 24680923
    [Abstract] [Full Text] [Related]

  • 16. Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia.
    Garrido P, Ribeiro S, Fernandes J, Vala H, Rocha-Pereira P, Bronze-da-Rocha E, Belo L, Costa E, Santos-Silva A, Reis F.
    Int J Mol Sci; 2015 Dec 25; 17(1):. PubMed ID: 26712750
    [Abstract] [Full Text] [Related]

  • 17. Jian-Pi-Yi-Shen formula ameliorates renal fibrosis-induced anemia in rats with chronic kidney disease.
    Huang H, Huang S, Li C, Zhang C, Wang R, Wei L, Wu J, Mo P, Li Z, Li S, Chen J.
    J Ethnopharmacol; 2024 Dec 05; 335():118607. PubMed ID: 39069029
    [Abstract] [Full Text] [Related]

  • 18. Functional erythropoietin-hepcidin axis in recombinant human erythropoietin independent haemodialysis patients.
    Touzot M, Lefebvre T, Roux A, Maheas C, Ridel C, Puy H, Karim Z.
    Nephrology (Carlton); 2019 Jul 05; 24(7):751-757. PubMed ID: 30175513
    [Abstract] [Full Text] [Related]

  • 19. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis.
    Menon MP, Karur V, Bogacheva O, Bogachev O, Cuetara B, Wojchowski DM.
    J Clin Invest; 2006 Mar 05; 116(3):683-94. PubMed ID: 16511603
    [Abstract] [Full Text] [Related]

  • 20. The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse Model.
    Noonan ML, Ni P, Agoro R, Sacks SA, Swallow EA, Wheeler JA, Clinkenbeard EL, Capitano ML, Prideaux M, Atkins GJ, Thompson WR, Allen MR, Broxmeyer HE, White KE.
    J Bone Miner Res; 2021 Jun 05; 36(6):1117-1130. PubMed ID: 33592127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.